Riess, Hanno <br/><br/>
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).  [electronic resource] 

 -  BMC cancer  Dec 2008 
 - 361 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-8-361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Anticoagulants--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Creatinine--blood<br/>Deoxycytidine--administration & dosage<br/>Drug Interactions<br/>Enoxaparin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Karnofsky Performance Status<br/>Male<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--prevention & control<br/>Pancreatic Neoplasms--blood supply<br/>Prospective Studies<br/>Research Design<br/>Survival Analysis<br/>Swine<br/>Venous Thromboembolism--prevention & control<br/>Gemcitabine